| Original language | English |
|---|---|
| Pages (from-to) | 1422-1423 |
| Number of pages | 2 |
| Journal | Alimentary Pharmacology & Therapeutics |
| Volume | 52 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 1 Oct 2020 |
Letter: ACE2, IBD and COVID-19—why IBD patients may be at reduced risk of COVID-19
Ralley E. Prentice, Doug Tjandra, Mayur Garg, John S. Lubel, Spiros Fourlanos, Doug Johnson, Aysha Al-Ani, Britt Christensen
Research output: Contribution to journal › Letter › Other › peer-review
2
Citations
(Scopus)